Diplegia is the bilateral, symmetrical loss or impairment of voluntary motor function affecting corresponding body parts on both sides — classically the lower limbs — distinguished from paraplegia (which involves the lower body without the symmetry/correspondence qualifier and typically implies a spinal cord etiology) and from hemiplegia (which affects one entire side of the body) by its characteristic bilateral, mirror-image distribution. In its most clinically prevalent form, spastic diplegia is a subtype of cerebral palsy caused by periventricular leukomalacia (PVL) — ischemic white matter injury near the lateral ventricles that preferentially damages the descending corticospinal fibers controlling the lower extremities, which arc closer to the ventricles than those serving the upper limbs — making lower extremity involvement disproportionately greater than upper extremity involvement (G80.1). The underlying mechanism is an upper motor neuron (UMN) lesion producing spastic-type paralysis, characterized by hypertonia, hyperreflexia, scissoring gait, equinus foot positioning, and hip adductor tightness — all resulting from loss of descending inhibitory corticospinal input to spinal motor circuits. Diplegia also occurs as a non-CP acquired form involving the upper limbs (G83.0) — bilateral upper extremity paralysis from bilateral brachial plexus injury, cervical cord lesion, or bilateral cortical insult — which is coded entirely separately from the CP-related lower limb diplegic pattern. It is commonly confused with paraplegia — note the key difference: paraplegia specifically denotes loss of function in the lower half of the body due to spinal cord injury (coded G82.20-G82.22), while diplegia implies bilateral symmetrical limb involvement of the same limb pair (upper or lower) from a brain or bilateral cortical/white matter lesion, not a spinal cord transection.
Greek plēgē (PLAY-gay), from plēssein (PLAYS-ein) “to strike, to hit”
Noun-forming suffix — “a stroke,” “a blow,” “paralysis” — in medical usage: “paralysis of (a specified body region)”
The word entered English in the 1880s as diplegia (noun), formed from New Latin, combining Greek di- (“two, double”) + Greek -plēgia (“a stroke, paralysis”) — literally “a double stroke” or “paralysis of two [corresponding] parts.” The suffix -plegia (from plēssein, “to strike”) reflects the ancient Greek conception of stroke as a “blow” or “striking down” of motor function, and connects diplegia to the entire -plegia root family: hemiplegia (hemi- + plegia → paralysis of half [the body]), quadriplegia (quadri- + plegia → paralysis of four limbs), paraplegia (para- + plegia → paralysis beside/alongside [the trunk]), and monoplegia (mono- + plegia → paralysis of one limb). The prefix di- is highly productive in medical and scientific terminology, appearing in diplopia, diphenyl, dichromia, diplegia, and disaccharide.
🔀 ALIASES / ALTERNATE TERMS
Diparesis(partial/incomplete form of diplegia — bilateral symmetrical weakness without complete loss; functionally equivalent term used interchangeably in operative and clinic notes; maps to the same ICD-10-CM codes as diplegia in most contexts)
Spastic Diplegia(most common subtype — UMN-pattern bilateral lower extremity spasticity due to PVL in premature neonates; the hallmark phenotype of G80.1 spastic diplegic cerebral palsy; characterized by scissor gait, equinus, and hip adductor spasm)
Spastic Diplegic Cerebral Palsy(the most common clinical entity associated with diplegia; coded G80.1; also known as “Little’s disease” historically; premature birth is the primary risk factor; periventricular leukomalacia on MRI is the pathologic hallmark)
Little’s Disease(historical eponym for spastic diplegic cerebral palsy; named after William John Little (1843); no longer used in formal coding but may appear in older medical records and operative notes — maps to G80.1)
Diplegia of Upper Limbs(bilateral paralysis of both arms — the non-CP acquired form; coded G83.0; caused by bilateral brachial plexus injury, cervical myelopathy, or bilateral cortical lesions; distinct from lower limb diplegic CP)
Congenital Diplegia(perinatal-onset bilateral motor impairment; almost always synonymous with spastic diplegic CP; coded G80.1; “congenital” reflects onset at or before birth)
Diplegic(adjective form — e.g., “diplegic gait,” “diplegic cerebral palsy,” “diplegic pattern of involvement”; used extensively in neurological examination documentation and operative reports)
Periventricular Leukomalacia (PVL)(the primary neuropathological substrate of spastic diplegia in preterm neonates; white matter ischemic injury near the lateral ventricles; coded P91.2 for the neonatal period; the MRI finding that clinches the spastic diplegia diagnosis)
Scissor Gait(pathognomonic functional hallmark of spastic diplegia — bilateral hip adductor/internal rotator spasm causing legs to cross midline during ambulation; documented as a clinical feature, not a separate diagnosis code)
🔗 RELATED TERMS
Cerebral Palsy — the most common underlying etiology of diplegia; nonprogressive, permanent motor disorder from prenatal/perinatal brain injury; spastic diplegia (G80.1) is the most common CP subtype, representing ~40% of all CP cases; unlike acquired paralysis, CP is never coded with G82.x — always use G80.x family
Paraplegia — the most commonly confused term with diplegia; paraplegia refers to lower-body motor loss from spinal cord injury/disease (G82.20-G82.22), while diplegia refers to bilateral symmetrical limb involvement from brain/bilateral cortical lesion; the etiological and neuroanatomical distinction determines code family (G80.1 vs. G82.x)
Hemiplegia — paralysis of one side of the body; spastic hemiplegic CP (G80.2) is a sibling ICD-10-CM code to spastic diplegic CP (G80.1); both fall under the G80.x cerebral palsy family and share the UMN/spastic mechanism but differ in body distribution
quadriplegia / Spastic Quadriplegic Cerebral Palsy — more severe bilateral involvement affecting all four limbs equally; coded G80.0 when CP-related; spastic quadriplegia is the most severe form of spastic CP, often with concurrent intellectual disability, seizures, and bulbar involvement
Periventricular Leukomalacia (PVL) — primary neuropathological cause of spastic diplegia; ischemic white matter necrosis in the periventricular zones adjacent to the lateral ventricles in preterm neonates; coded P91.2 when documented in the neonatal period
Spasticity — velocity-dependent hypertonia; the defining motor sign of spastic diplegia; managed with botulinum toxin injections (64644-64645), oral baclofen, intrathecal baclofen pump (62362), and selective dorsal rhizotomy (63190); coded separately as a manifestation — never as a substitute for the G80.1 diagnosis
Selective Dorsal Rhizotomy (SDR) — primary neurosurgical treatment for spastic diplegia in carefully selected ambulatory children with CP; involves selective sectioning of L1-S2 dorsal nerve rootlets to permanently reduce lower limb spasticity; coded 63190; payer prior auth is required and diagnosis of G80.1 is the expected principal indication
Intrathecal Baclofen Therapy — pharmacological spasticity management via implanted intrathecal pump delivering baclofen directly to the spinal cord; coded 62362 (implant/replace) or 62367-62370 (electronic analysis); used when oral baclofen fails and patient is not SDR candidate
Botulinum Toxin Injection — chemodenervation of spastic muscle groups in diplegia (gastrocnemius, hamstrings, hip adductors, iliopsoas); coded 64644 (1-4 muscles, one extremity) or 64645 (5+ muscles, one extremity); both extremities require separate code pairs; among the highest-volume procedures for pediatric spastic diplegia management
Gait Analysis — three-dimensional computerized motion analysis used to objectively quantify the diplegic gait pattern and guide surgical/therapeutic planning; coded 96000 (comprehensive gait evaluation with dynamic plantar pressure); required by many payers prior to SDR authorization
Physical Therapy — cornerstone of diplegia management throughout the lifespan; coded 97110 (therapeutic exercise, per 15 min) and 97530 (therapeutic activities, per 15 min); essential pre- and post-SDR rehabilitation component
Orthotics / AFO — ankle-foot orthoses are the most commonly prescribed assistive devices for spastic diplegia; manage equinus and improve gait; HCPCS coded (L1900-L1990 range for AFOs); frequently billed concurrent with PT and botulinum toxin episodes of care
Chemodenervation of one extremity; 5 or more muscles (botulinum toxin injection — spastic diplegia, per extremity, 5+ muscles; report separately for each extremity treated)
Chemodenervation of trunk muscle(s); 1-5 muscle(s) (botulinum toxin — trunk/paraspinal muscles; used when iliopsoas or paraspinal injected)
64647
Chemodenervation of trunk muscle(s); 6 or more muscles (botulinum toxin — trunk; extensive trunk involvement)
63190
Laminectomy with rhizotomy; more than 2 segments (selective dorsal/posterior rhizotomy — primary surgical treatment for spastic diplegia; L1-S2 dorsal rootlet sectioning)
62362
Implantation or replacement of device for intrathecal or epidural drug infusion; programmable pump, including preparation of pump with or without programming (intrathecal baclofen pump implant — when SDR not indicated or failed)
62367
Electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion; without reprogramming or refill
62368
Electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion; with reprogramming
62369
Electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion; with reprogramming and refill
62370
Electronic analysis of programmable, implanted pump for intrathecal or epidural drug infusion; with reprogramming and refill (requiring skill of physician or other qualified health care professional)
96000
Comprehensive computer-based motion analysis by video-taping and 3-D kinematics; dynamic plantar pressure measurements during walking (gait analysis — required for SDR pre-authorization in most payers)
Therapeutic procedure; therapeutic exercises to develop strength, endurance, range of motion, and flexibility (15 min — PT for spastic diplegia rehab; pre- and post-SDR)
Therapeutic activities; direct patient contact (15 min — functional motor retraining and activities of daily living)
97542
Wheelchair management and propulsion training; each 15 minutes (for non-ambulatory severe diplegic CP patients)
⚠️ Coding Note: For inpatient profee diplegia coding, the single most important distinction is G80.1 (spastic diplegic CP) vs. G83.0 (diplegia of upper limbs, acquired) — these two codes represent fundamentally different diagnoses with different etiologies, body regions, and clinical contexts; using G83.0 when the patient actually has spastic diplegic CP is a payer audit red flag that will mismatch DRG grouping. Never code G82.20-G82.22 (paraplegia) for a patient with spastic diplegic cerebral palsy — the ICD-10-CM Excludes1 notation under G82 explicitly excludes CP; if a coder sees “diplegic paralysis” in a pediatric patient’s chart without CP specified, always query the attending to clarify CP vs. acquired etiology before assigning G82.x. G80.1 is a CC (complication/comorbidity) per CMS MS-DRG guidelines — so when a patient with known spastic diplegic CP is admitted for another reason (e.g., orthopedic procedure, pneumonia, baclofen pump revision), capturing G80.1 as an additional diagnosis directly impacts DRG weight and reimbursement. For botulinum toxin billing (64644-64645), each extremity is billed separately — bilateral lower extremity injections in a diplegic patient = two separate line items (64644 or 64645 × 2, one per extremity); payers will bundle without the separate extremity documentation in the procedure note. Undercoding alert: When a child with spastic diplegia undergoes SDR (63190), the pre-authorization almost universally requires a formal gait analysis (96000) — this code is routinely omitted on profee claims because it is performed in a separate physical therapy/motion analysis lab visit; if the physician ordered and reviewed the gait analysis report, the professional component is reportable. Modifier -52 (reduced services) is appropriate when a planned bilateral botulinum toxin injection session is only partially completed due to patient tolerance.
Crystal's Coder Hub